Recently, it has been reported that Drosha, a key enzyme in miRNA biogenesis, regulates vascular development and homeostasis via the TGFβ/BMP pathway, and rare missense mutations in the Drosha gene may predispose carriers to HHT [21,22]. This evidence concerns the gene TGFB1 and hereditary hemorrhagic telangiectasia.